Breaking News Bar

Business News and Information

$15M deal: Exton biomaterials manufacturer expands partnership with ophthalmic pharmaceutical firm

Aerie Pharmaceuticals and DSM Biomedical are working on sustained-release drug delivery devices to treat a broad spectrum of eye diseases.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear